Table 2 Univariate analysis
From: Molecular diagnostics helps to identify distinct subgroups of spinal astrocytomas
Univariate analysis | |||
|---|---|---|---|
p-value | HR | 95% CI for HR | |
Age (continuously) | 0.002 | 1.063 | 1.022–1.105 |
Female Gender (vs. male) | 0.05 | 0.127 | 0.016–0.998 |
Localization (cervical vs. thoracic) | 0.228 | 0.509 | 0.170–1.526 |
Mutation H3F3A (yes vs.no) | 0.03 | 4.164 | 1.038–15.801 |
ATRX loss (yes vs. no) | 0.085 | 0.119 | 0.011–1.337 |
Necrosis (yes vs. no) | 0.650 | 0.045 | 0.136–9.092 |
Endothelial Proliferation (yes vs. no) | 0.222 | 2.108 | 0.637–6.977 |
Mitosis (continuously) | 0.059 | 1.653 | 0.981–2.784 |
Ki-67 (continuously) | 0.057 | 10.428 | 0.75–43.398 |
Tumor Subtype | 0.002 | 0.42 | 0.244–0.724 |
Adjuvant Treatment (yes vs no) | 0.154 | 3.063 | 0.657–14.289 |